Ista Xibrom To Launch By Early June At Premium To Allergan Acular
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA clears ophthalmic NSAID March 24 for postoperative inflammation following cataract surgery. Ista plans to complete scale-up of 70-rep sales force over the next several weeks, CEO Vince Anido says.